Related Experiment Videos

[Coronary artery bypass grafting in six patients with familial hypercholesterolemia]

T Hiranaka1, N Sakagoshi, Y Furutani

  • 1Department of Cardiovascular Surgery, Kinan General Hospital, Wakayama, Japan.

Insights

Coronary artery bypass grafting (CABG) is effective for familial hypercholesterolemia (FH) patients, showing a 100% graft patency rate and no early deaths. Surgical interventions in FH patients yielded positive short-term outcomes.

Area of Science:

  • Cardiovascular Surgery
  • Medical Genetics
  • Vascular Surgery

Background:

  • Familial hypercholesterolemia (FH) is a genetic disorder leading to high cholesterol and premature cardiovascular disease.
  • Surgical interventions are considered for FH patients with severe coronary artery disease.
  • Coronary artery bypass grafting (CABG) is a common surgical procedure for managing coronary artery disease.

Observation:

  • Six patients with familial hypercholesterolemia underwent surgical treatment between June 1989 and November 1991.
  • Procedures included isolated CABG, CABG with coronary aneurysm ligation, and CABG with femoro-femoral bypass.
  • A specific case involved a 44-year-old man with recurrent angina 11 years post-CABG, who underwent successful aneurysm ligation and internal mammary artery grafting.

Findings:

  • There were no operative or hospital deaths among the six patients.
  • The early postoperative graft patency rate was 100%.
  • The patient undergoing aneurysm ligation remained asymptomatic postoperatively, indicating successful management.

Implications:

  • CABG demonstrates effectiveness in the early postoperative period for patients with familial hypercholesterolemia.
  • Surgical management, including complex procedures like aneurysm ligation, can be beneficial for FH patients.
  • These findings support the role of surgical intervention in managing advanced coronary artery disease in FH.
Abstract

Related Concept Videos